RFA
LKFT

Reilly Financial Advisors’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Reilly Financial Advisors’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-3
Closed – – 1003
2018
Q1 		$0 Buy
+3
New +$323 ﹤0.01% 1007

Other funds holding LKFT

Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Reilly Financial Advisors's LKFT Position: Q2 2018 in Review

Reilly Financial Advisors sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2018, closing a stake of 3 shares.

Reilly Financial Advisors first reported a position in LKFT in Q1 2018 and held it in 1 quarter. The position peaked at $0 in Q1 2018. 79 funds tracked by Wall St. Rank hold LKFT as of Q2 2018.

  • Reilly Financial Advisors reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q2 2018 after selling out during the quarter.
  • Reilly Financial Advisors sold 3 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2018.
  • Reilly Financial Advisors first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2018 and held it in 1 quarter.
  • Reilly Financial Advisors's Lakefront Biotherapeutics American Depositary Shares position peaked at $0 in Q1 2018.
  • 79 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2018.

Based on Reilly Financial Advisors's 13F filing for Q2 2018, filed 18 Jul 2018.